TherapeuticsMD EVP Operations Edward Borkowski departs effective Sept 30, 2021

TherapeuticsMD, Inc.

Mr. Borkowski and company mutually agreed to separation; departure effective September 30, 2021.
Separation treated as 'Good Reason' under Oct 2019 employment agreement; eligible for contractual severance benefits.
No successor named; responsibilities reassigned among remaining executives.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Edward Borkowski

Executive Vice President, Operations

TXMD · TherapeuticsMD, Inc.

Effective: 2021-09-30
Filed: October 1, 2021, 7:59 PM ET

On September 30, 2021, TherapeuticsMD, Inc., a Nevada corporation (the “Company”), and Mr. Edward Borkowski, Executive Vice President, Operations of the Company, mutually agreed that Mr. Borkowski would separate from the Company, effective as of such date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Edward Borkowski departed as Executive Vice President, Operations at TherapeuticsMD, Inc..

Action: separated
Role: Executive Vice President, Operations

Exact text from the filing

On September 30, 2021, TherapeuticsMD, Inc., a Nevada corporation (the “Company”), and Mr. Edward Borkowski, Executive Vice President, Operations of the Company, mutually agreed that Mr. Borkowski would separate from the Company, effective as of such date.

View on SEC.gov

TherapeuticsMD, Inc. filing history →

Source: SEC EDGAR

accession 0001564590-21-049852

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.